|
HCFC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.386760E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.229900E-04 |
| Normal-vs-Stage2 |
9.092300E-02 |
| Normal-vs-Stage3 |
7.59559999999881E-05 |
| Normal-vs-Stage4 |
1.994630E-04 |
| Stage1-vs-Stage2 |
2.534400E-01 |
| Stage1-vs-Stage3 |
3.303800E-01 |
| Stage1-vs-Stage4 |
3.522800E-01 |
| Stage2-vs-Stage3 |
8.702200E-02 |
| Stage2-vs-Stage4 |
1.183610E-01 |
| Stage3-vs-Stage4 |
9.730400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.634800E-04 |
| Normal-vs-AfricanAmerican |
2.996400E-01 |
| Normal-vs-Asian |
4.861000E-03 |
| Caucasian-vs-AfricanAmerican |
1.318160E-01 |
| Caucasian-vs-Asian |
9.887800E-01 |
| AfricanAmerican-vs-Asian |
1.714200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.21450000000134E-05 |
| Normal-vs-Female |
4.801900E-04 |
| Male-vs-Female |
2.655400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.099180E-03 |
| Normal-vs-Age(41-60Yrs) |
3.436700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.618600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.417600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.007400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.312000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.720800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.928600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.633600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.402400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.205780E-02 |
| Classical-VS-Follicular |
1.481900E-03 |
| Classical-VS-Other |
2.051500E-02 |
| Classical-VS-Normal |
5.916900E-03 |
| Tall-VS-Follicular |
6.952400E-01 |
| Tall-VS-Other |
2.496600E-01 |
| Tall-VS-Normal |
5.51850000000131E-05 |
| Follicular-VS-Other |
2.681800E-01 |
| Follicular-VS-Normal |
2.06509999999271E-05 |
| Other-VS-Normal |
1.135710E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.180930E-03 |
| Normal-vs-N1 |
2.07629999999792E-05 |
| N0-vs-N1 |
9.134100E-02 |
|
|
